Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Ultrasound-guided transversalis fascia plane block for pain after inguinal lymph node dissection

Official title: Evaluation of Peri-operative Analgesic Efficacy of Ultrasound Guided Transversalis Fascia Plane Block in Cancer Patients Undergoing Inguinal Lymph Node Dissection: A Prospective Randomized Controlled Study

Run by National Cancer Institute, Egypt · NCT07331129 · Data updated 2026-11-12

This will test whether an ultrasound-guided transversalis fascia plane block can reduce pain and opioid needs for adult cancer patients having inguinal lymph node removal.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment90 (estimated)
SponsorNational Cancer Institute, Egypt
Academic / other
Locations1 site (Cairo)
StatusRecruiting
StartedDecember 22, 2025
Main results expectedJune 28, 2026
Study endsJune 29, 2026
Registry record updatedJanuary 9, 2026
Trial IDNCT07331129 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 with cancer scheduled for inguinal lymph node dissection who are ASA I–II and have a BMI of 20–40 kg/m2, and who do not have infection at the puncture site, significant coagulopathy, unstable heart disease, or allergies to the anesthetics used.

Probably not a fit

Patients with local infection at the puncture site, platelets below 50,000 or INR >1.6, unstable cardiovascular disease, severe psychiatric/cognitive disorders, or allergy to the study medications would not be eligible and are unlikely to benefit from this procedure.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional trial compares an ultrasound-guided transversalis fascia plane block to surgical-site local anesthetic infiltration for postoperative pain control in adults undergoing inguinal lymph node dissection. The block is performed under ultrasound guidance to target the transversalis fascia plane and the study will track pain scores, opioid consumption, and common opioid-related side effects after surgery. Eligible participants are cancer patients aged 18–65 with ASA class I–II and BMI between 20 and 40 kg/m2, without major bleeding risk or unstable cardiovascular disease. The work is conducted at the National Cancer Institute, Cairo University with standard perioperative monitoring and follow-up.

Why it matters

Potential benefit: If successful, the block could provide better pain control after surgery while reducing opioid use and opioid-related side effects.

How similar studies have gone: Related abdominal wall and fascial-plane blocks such as TAP and TFPB have shown reduced postoperative pain and opioid use in hernia and other abdominal surgeries, but use of TFPB specifically for inguinal lymph node dissection is less well studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. American society of anesthesiologists (ASA) class I and II.
2. Age ≥ 18 and ≤ 65 Years.
3. Cancer patients for inguinal lymph node dissection.
4. Body mass index (BMI): \> 20 kg/m2 and \< 40 kg/m2.

Exclusion Criteria:

1. Patient refusal.
2. Local infection at the puncture site.
3. Coagulopathies with platelets count below 50,000 or an INR\>1.6.
4. Unstable cardiovascular disease.
5. History of psychiatric and cognitive disorders.
6. Patients allergic to medication used.

Where it's running

  • National Cancer Institute Cairo University
    Cairo, Egypt
    Recruiting

Study contacts

  • Principal investigator: Ayman Sharawy Abdel Rahman Aboul Nasr, MD — National Cancer Institute Cairo University
  • Study coordinator: Ayman Sharawy Abdel Rahman Aboul Nasr, MD
  • Email: ayman.sharawy@nci.cu.edu.eg
  • Phone: 01282649008

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.